NCT01301040 - Early Cardiac Toxicity of Adjuvant CT in Elderly BC. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2016

Conditions

Breast Cancer

Interventions

DRUG

epirubicin, cyclophosphamide, docetaxel

"* Treatment arm 1: EC - epirubicin (100mg/m2 IV) and cyclophosphamide (600mg/m2 IV) every 3 weeks for 4 cycles.~* Treatment Arm 2: TC - docetaxel (75mg/m2 IV) and cyclophosphamide (600mg/m2 IV) every 3 weeks for 4 cycles."

Trial Locations (1)

1000

Institut Jules Bordet, Brussels